首页> 外文期刊>International Journal of Cardiology >Post-interventional cardiac biomarker release has lower prognostic relevance compared with standard risk markers in patients with stable coronary artery disease undergoing elective percutaneous coronary interventions
【24h】

Post-interventional cardiac biomarker release has lower prognostic relevance compared with standard risk markers in patients with stable coronary artery disease undergoing elective percutaneous coronary interventions

机译:接受选择性经皮冠状动脉介入治疗的稳定冠心病患者,与标准危险标志物相比,介入后心脏生物标志物释放的预后相关性较低

获取原文
获取原文并翻译 | 示例
           

摘要

The clinical relevance of post-interventional cardiac troponin release after elective percutaneous coronary interventions (PCI) in patients without overt signs of peri-interventional myocardial ischemia is still controversially discussed particularly in the field of interventional cardiology [1] despite rising the decision limit for cardiac troponins for the diagnosis of Type IVa myocardial infarction in the recent update of the universal definition of myocardial infarction to 5 times of the upper reference limit (URL) [2]. Therefore, we investigated the prognostic impact of post-interventional cardiac troponin T (cTnT) and creatine kinase (CK) release compared with established risk factors and risk markers in patients with stable coronary artery disease (CAD) undergoing elective, clinically uncomplicated PCI during long-term follow-up in a prospective cohort study.
机译:对于无明显介入性心肌缺血迹象的选择性经皮冠状动脉介入治疗(PCI)后,介入性心肌肌钙蛋白释放的临床意义仍存在争议,特别是在介入性心脏病学领域[1]肌钙蛋白可用于诊断IVa型心肌梗死,最近将心肌梗死的通用定义更新为参考上限(URL)的5倍[2]。因此,我们调查了长期稳定的冠状动脉疾病(CAD)患者在长期进行择期,临床上不复杂的PCI的情况下,与确定的危险因素和危险标志物相比,干预后心脏肌钙蛋白T(cTnT)和肌酸激酶(CK)释放对预后的影响一项前瞻性队列研究的长期随访。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号